Literature DB >> 6207779

Injection-site granuloma due to aluminum.

H A Fawcett, N P Smith.   

Abstract

Three patients had subcutaneous nodules at the sites of previous injections of vaccine containing tetanus toxoid. Biopsy and microscopic findings in all three cases showed foci of granulomatous inflammation, consisting of lymphoid follicles, in the deep dermis and subcutaneous tissues and a surrounding infiltrate of lymphocytes, histiocytes, plasma cells, and eosinophils. Occasional zones of eosinophilic necrosis were seen within the inflammatory foci, and surrounding dense fibrous bands were present in some areas. A solochrome-azurin stain showed aluminum crystals in the nodules from two patients. From the evidence available, we believe that these nodules are a complication of inoculations with aluminum-containing vaccines.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6207779

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  16 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  How common are long-lasting, intensely itching vaccination granulomas and contact allergy to aluminium induced by currently used pediatric vaccines? A prospective cohort study.

Authors:  Elisabet Bergfors; Göran Hermansson; Ulla Nyström Kronander; Lars Falk; Lars Valter; Birger Trollfors
Journal:  Eur J Pediatr       Date:  2014-04-22       Impact factor: 3.183

3.  M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP).

Authors:  Jamie-Lee S Mills; Cesar M Jayashi Flores; Manisha Pandey; Michael F Good; Simone Reynolds; Christine Wun; Ainslie Calcutt; S Ben Baker; Senthil Murugappan; Alexandra C I Depelsenaire; Jessica Dooley; Paul V Fahey; Angus H Forster
Journal:  NPJ Vaccines       Date:  2020-08-07       Impact factor: 7.344

4.  Nineteen cases of persistent pruritic nodules and contact allergy to aluminium after injection of commonly used aluminium-adsorbed vaccines.

Authors:  Elisabet Bergfors; Cecilia Björkelund; Birger Trollfors
Journal:  Eur J Pediatr       Date:  2005-07-26       Impact factor: 3.183

5.  Sixty-four children with persistent itching nodules and contact allergy to aluminium after vaccination with aluminium-adsorbed vaccines-prognosis and outcome after booster vaccination.

Authors:  Elisabet Bergfors; Birger Trollfors
Journal:  Eur J Pediatr       Date:  2012-10-11       Impact factor: 3.183

6.  Absence of skin sensitivity to oxides of aluminium, silicon, titanium or zirconium in patients with Crohn's disease.

Authors:  J C Lee; S Halpern; D G Lowe; A Forbes; J E Lennard-Jones
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

7.  Aluminium and injection site reactions.

Authors:  G A Culora; A D Ramsay; J M Theaker
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

8.  Incidence rate of injection-site granulomas resulting from the administration of luteinizing hormone-releasing hormone analogues for the treatment of prostatic cancer.

Authors:  Masaki Shiota; Noriaki Tokuda; Takehiro Kanou; Humio Yamasaki
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

9.  Replication of Small Ruminant Lentiviruses in Aluminum Hydroxide-Induced Granulomas in Sheep: a Potential New Factor for Viral Dissemination.

Authors:  Irache Echeverría; Ricardo de Miguel; Lluís Luján; Ramsés Reina; Javier Asín; Ana Rodríguez-Largo; Antonio Fernández; Marta Pérez; Damián de Andrés
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

10.  Bilateral injection-site granuloma by subcutaneous administration of luteinizing hormone-releasing hormone analogue: a case report.

Authors:  Riko Kitazawa; Fukashi Yamamichi; Toshiharu Hidaka; Shinichi Morishita; Takeshi Kondo; Kiyoshi Mori; Sohei Kitazawa
Journal:  Cases J       Date:  2009-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.